Please note, Alexar has changed its name to Ralexar
Dr. Hong is a Principal at Third Point LLC, an event driven hedge fund based in New York City. At Third Point, Dr. Hong is responsible for public and private investments across all healthcare subsectors. Before joining Third Point, Dr. Hong worked previously at Goldman Sachs, Polygon Investment Partners and Sanford C. Bernstein. Prior to Bernstein, Dr. Hong spent four years at McKinsey & Company, working with global healthcare companies in the areas of business development, post-merger integration and clinical program development. Dr. Hong holds a Ph.D. in Chemistry from Harvard University, and a B.S. with Honors in Chemistry from the California Institute of Technology.